This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ADRNY or KMB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADRNY vs. KMB: Which Stock Is the Better Value Option?
Stock Market News for Apr 23, 2025
by Zacks Equity Research
U.S. stocks closed sharply higher on Tuesday on optimism that trade tensions between the United States and China could de-escalate in the coming days, while President Donald Trump said he has no immediate plans to fire Federal Reserve Chairman Jerome Powell.
Kimberly-Clark's Q1 Earnings Top Estimates, Organic Sales Down 1.6%
by Zacks Equity Research
KMB's first quarter sales dip 6%, with organic sales declining 1.6%. Management updates 2025 outlook amid cost pressures and global headwinds.
Kimberly-Clark (KMB) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Kimberly-Clark (KMB) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Kimberly-Clark (KMB) Tops Q1 Earnings Estimates
by Zacks Equity Research
Kimberly-Clark (KMB) delivered earnings and revenue surprises of 2.12% and 0.49%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kimberly-Clark Gears Up for Q1 Earnings: Key Factors to Note
by Zacks Equity Research
KMB's first-quarter results are likely to reflect pressure from soft demand, retail destocking and input cost inflation across key segments.
Albertsons' Q4 Earnings Beat Estimates, Pharmacy Sales Rise 18% Y/Y
by Zacks Equity Research
ACI's fourth-quarter fiscal 2024 results showcase strong year-over-year growth in digital sales, pharmacy operations and membership in its loyalty program.
Analysts Estimate Kimberly-Clark (KMB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Kimberly-Clark (KMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Kimberly-Clark (KMB) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RH (RH) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
RH (RH) delivered earnings and revenue surprises of -17.28% and 1.80%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
KMB Stock Gains 10% in 3 Months: Should You Buy Now or Hold Steady?
by Zacks Equity Research
Kimberly-Clark drives growth through innovation, premium products and global expansion while navigating challenges like currency volatility and shifting demand.
KLG or KMB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
KLG vs. KMB: Which Stock Is the Better Value Option?
Zacks Industry Outlook The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox
by Zacks Equity Research
The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox have been highlighted in this Industry Outlook article.
4 Consumer Product Stocks to Keep an Eye on Despite Market Challenges
by Ansuiya Mohta
The Zacks Consumer Products - Staples industry is navigating a tough consumer environment and elevated SG&A costs. Nevertheless, PG, CL, KMB and CLX are leveraging innovations to drive growth.
Is February Retail Sales Really Weak? ETFs to Benefit
by Sanghamitra Saha
Retail sales rose by 0.2% in February, a rebound from the downwardly revised 1.2% decline in January.
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
KMB Trades Above 50 & 200-Day SMA: How Should Investors Play?
by Zacks Equity Research
Kimberly-Clark is driving growth through innovation and market expansion while navigating economic pressures and currency headwinds.
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
"R-Word" Fears Send Stock Market Much Lower
by Mark Vickery
While the tech-heavy Nasdaq and small-cap Russell 2000 are both -11% over the past month, the Dow is down "only" half that.
Why Is Kimberly-Clark (KMB) Up 7.3% Since Last Earnings Report?
by Zacks Equity Research
Kimberly-Clark (KMB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kimberly-Clark Up 7% in a Month: Is the Stock Still a Good Buy?
by Zacks Equity Research
KMB focuses on growth through innovation, premium products and global expansion, despite challenges from currency volatility and softening demand.
Kimberly-Clark Meets Q4 Earnings Estimates, Announces Dividend Hike
by Zacks Equity Research
KMB's Q4 sales and earnings decline year over year. However, organic sales rise on improved volumes and pricing.
Kimberly-Clark (KMB) Q4 Earnings Match Estimates
by Zacks Equity Research
Kimberly-Clark (KMB) delivered earnings and revenue surprises of 0% and 1.93%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
4 Consumer Staple Stocks Likely to Top Earnings Estimates This Season
by Vrishali Bagree
Companies with solid brands and efficient cost-management efforts are poised to shine amid a dynamic consumer landscape. KMB, CHD, CLX and KVUE are in focus.